SW

Steven Wang

Orbimed Healthcare Investments Fund (Offshore) LP - Partner, Senior Managing Director

Huangpu District, Shanghai

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

China
Shanghai

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $75,000,000.00

  • Target Investment:

    $4,000,000.00

Skills

Valuation
Financial Modeling
Bloomberg
Equities
Equity Research
Fixed Income
Hedge Funds
Investment Banking
Capital Markets
Private Equity
Investments
Derivatives
Asset Management
Portfolio Management
Corporate Finance

Education

Lists including Steven

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Epigenic Therapeutics

Series A

Total Funding: $32M

HanBio Therapeutics

Series A

Total Funding: $40M

Work Experience

Orbimed Healthcare Investments Fund (Offshore) LP

2019

  • Partner, Senior Managing Director

    2019

C
CPE

2016 - 2019

  • Managing Director, Head of Pharmaceuticals

    2016 - 2019

CS
Credit Suisse

2014 - 2016

  • Managing Director, Head of Asia Healthcare Investment Banking

    2014 - 2016

    Advising cross-border M＆A and underwriting HK IPO and debt offerings

UI
UBS Investment Bank

2011 - 2014

  • Managing Director

    2011 - 2014

MS
Morgan Stanley

2007 - 2011

  • Executive Director

    2007 - 2011

    Investment Banking for Greater China healthcare and industrial sectors

ADAR Investment Management and Clinton Group

2004 - 2007

  • Analyst

    2004 - 2007

    Multi-strategy hedge-fund

SR
Schering-Plough Research Institute

1997 - 2000

  • Principal Research Scientist

    1997 - 2000

    Pharmaceutical research in Allergy and Immunology